CTRI/2010/091/001055
Completed
Phase 3
A randomized, open label, comparative, multicentric study to assess the efficacy and safety of Revaprazan tablets in comparison with Omeprazole capsules in patients suffering from Peptic Ulcer or Acute Gastritis
Overview
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Cadila Healthcare Ltd
- Enrollment
- 200
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of either sex of 19 to 75 years of age.
- •2\.Established diagnosis of peptic ulcer or acute gastritis.
- •3\.Informed consent of the patient/relative.
Exclusion Criteria
- •1\.Pregnancy or Lactation.
- •2\.Clinically significant disorder of liver, kidney, cardiovascular system, respiratory system, endocrine system and CNS.
- •3\.Not eligible to undergo endoscopy.
- •4\.Zollinger\-Ellison syndrome.
- •5\.Patients requiring use of any unacceptable concomitant medications
- •6\.Patients with any other serious concurrent illness or malignancy.
- •7\.Patients with continuing history of alcohol and / or drug abuse.
- •8\.Participation in another clinical trial in the past 3 months.
Investigators
Similar Trials
Completed
Phase 3
A clinical trial to study the effects of two drugs, fixed dose combination capsules of Celecoxib and Diacerein and fixed dose combination tablets of Aceclofenac and Diacerein in patients with osteoarthritis of knee and/or hip joints.Health Condition 1: M169- Osteoarthritis of hip, unspecifiedHealth Condition 2: null- Osteoarthritis of knee and/or hip jointsHealth Condition 3: M179- Osteoarthritis of knee, unspecifiedCTRI/2010/091/000053Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study effectiveness and safety of Fixed dose combination tablets of Hyoscine butylbromide & Mefenamic acid in patients suffering from paroxysmal spastic abdominal paiHealth Condition 1: R108- Other abdominal painHealth Condition 2: null- Paroxysmal spastic abdominal painCTRI/2011/091/000141Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study effectiveness and safety of Acrivastine capsules in comparison with Chlorpheniramine maleate tablets in patients suffering from allergic rhinitisHealth Condition 1: null- Allergic rhinitisHealth Condition 2: J309- Allergic rhinitis, unspecifiedCTRI/2010/091/001368Cadila Healthcare Ltd200
Completed
Phase 3
A clinical trial to study to assess effectiveness and safety of two medications for the treatment for schizophreniaCTRI/2011/091/000140Cadila Healthcare Ltd200
Unknown
Phase 4
To determine the efficacy and safety of a combination of Extended Release (ER) Niacin and Rosuvastatin as compared with Rosuvastatin alone in patients with Mixed Dyslipidemia.Health Condition 1: null- Mixed DyslipidemiaCTRI/2010/091/003016Troikaa Pharmaceuticals Ltd160